Drugs / EMLA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT05580029 Background | Nov 2022 → Jan 2023 | hidradenitis suppurativa | University of Southern California | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05580029 ↗ |
| Route | Topical | “Topical 30 minutes before each fractional ablative CO2 session” NCT05580029 ↗ |